COVID-19 vaccines target emerging variants, offering improved protection. Learn about their effectiveness, timing, and safety ...
For now, Moderna may be a good stock to put on a watch list, but it's likely too risky and volatile for the vast majority of ...
Norovirus infection rates are extremely high this year, raising the question: Why can’t a vaccine protect us from the stomach ...
The FDA has canceled an advisory committee's meeting on flu shot recommendations, raising concerns amid shifts in leadership ...
The JN.1-adapted COVID-19 vaccines for children aged six months to 11 years have been used up, so starting from yesterday, ...
Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...
Persistent levels of spike protein from COVID-19 vaccines could be associated with a range of chronic symptoms like excessive ...
A government advisory committee has canceled a meeting on flu shot recommendations, raising concerns amid shifts in ...